{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:53:03Z","timestamp":1789840383049,"version":"4.0.1"},"reference-count":34,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Anaplastic thyroid cancer (ATC) is a highly lethal malignancy in which early detection of progression could allow timely treatment modifications and potentially improve outcomes. Novel circulating tumor DNA (ctDNA) assays allow the detection of molecular residual disease. We aimed to investigate the utility of ctDNA as a biomarker in ATC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>Retrospective cohort study of patients with ATC and at least one ctDNA drawn before systemic therapy start (referred to as baseline) between February 2021 and August 2024. ctDNA was correlated with concomitant imaging and\/or pathologic results. Patients with \u22651 additional ctDNA on systemic therapy were included in a secondary analysis to evaluate the detection of ctDNA as a molecular evidence of disease recurrence\/progression. These patients were divided into two subgroups: recurrence detection after curative-intent therapy (group 1) or treatment response monitoring if known residual disease (group 2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Forty-five patients met the inclusion criteria. At baseline, ctDNA result correlated with disease status in 93% of patients (75% true positives, 18% true negatives, 7% false negatives [FNs], 0% false positive). Thirty-one patients had \u22651 follow-up ctDNA on systemic therapy, with a total of 130 evaluable results. In group 1(n = 60), ctDNA had 77% sensitivity, 100% specificity, 92% negative predictive value (NPV), and 100% positive predictive value (PPV). In group 2 (n = 70), ctDNA had 78% sensitivity, 100% specificity, 84% NPV, and 100% PPV. Potential reasons for FN ctDNA included low tumor burden, lung-only\/brain-only metastatic disease, and heterogeneous molecular profiles in ATC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>ctDNA is a promising tumor biomarker for disease monitoring in ATC, with a high specificity and PPV. It should be considered in addition to standard-of-care surveillance methods to better inform treatment decision making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-25-00067","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T15:59:10Z","timestamp":1750953550000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":7,"title":["Circulating Tumor DNA as a Biomarker for Disease Surveillance in Anaplastic Thyroid Cancer"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-9885","authenticated-orcid":true,"given":"Sarah","family":"Hamidi","sequence":"first","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Dadu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka C.","family":"Iyer","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-6378","authenticated-orcid":true,"given":"Naifa L.","family":"Busaidy","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-2841","authenticated-orcid":true,"given":"Anastasios","family":"Maniakas","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-3832","authenticated-orcid":true,"given":"Jennifer R.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.","family":"Banuchi","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-9928","authenticated-orcid":true,"given":"S. Mohsen","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-7332","authenticated-orcid":true,"given":"Michelle D.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-9739","authenticated-orcid":true,"given":"Mark E.","family":"Zafereo","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-1811","authenticated-orcid":true,"given":"Maria E.","family":"Cabanillas","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2010.03.013"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13124.1"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010179"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.2133"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.3362"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0504"},{"key":"e_1_3_5_9_2","article-title":"Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma","author":"Wang JR","unstructured":"Wang JR, Montierth M, Xu L, et al: Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma. JCO Precis Oncol 10.1200\/PO.21.00504","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.4729"},{"key":"e_1_3_5_11_2","first-page":"214","article-title":"Accuracy of PET\/CT in characterization of solitary pulmonary lesions","volume":"48","author":"Kim SK","year":"2007","unstructured":"Kim SK, Allen-Auerbach M, Goldin J, et al: Accuracy of PET\/CT in characterization of solitary pulmonary lesions. J Nucl Med 48:214-220, 2007","journal-title":"J Nucl Med"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.760"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-0096-5"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02052"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3663"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1253629"},{"key":"e_1_3_5_17_2","article-title":"Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases","author":"Loupakis F","unstructured":"Loupakis F, Sharma S, Derouazi M, et al: Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases. JCO Precis Oncol 10.1200\/PO.21.00101","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03642-9"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0528"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0296"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0076"},{"key":"e_1_3_5_22_2","article-title":"Circulating BRAF V600E cell-free DNA as a biomarker in the management of anaplastic thyroid carcinoma","author":"Iyer PC","unstructured":"Iyer PC, Cote GJ, Hai T, et al. Circulating BRAF V600E cell-free DNA as a biomarker in the management of anaplastic thyroid carcinoma. JCO Precis Oncol 10.1200\/PO.18.00173","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1072"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1349"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.007"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.LIQBIOP24-B024"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113826"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4637-6"},{"key":"e_1_3_5_29_2","article-title":"Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer","author":"Bando H","unstructured":"Bando H, Nakamura Y, Taniguchi H, et al: Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer. JCO Precis Oncol 10.1200\/PO.21.00535","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0049"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169653"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12553-6"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.255"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.978996"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3926"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-00067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T15:59:17Z","timestamp":1750953557000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-00067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1200\/PO-25-00067"],"URL":"https:\/\/doi.org\/10.1200\/po-25-00067","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2025-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500067"}}